Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
4D Pharma
Biotech
4D Pharma sinks into administration as creditor calls in loans
4D Pharma has gone into administration after failing to secure a loan to help ride out the “difficult” market conditions.
James Waldron
Jun 27, 2022 9:09am
Despite 0% response rate, 4D hits primary goal in cancer trial
Mar 23, 2022 7:45am
Arena Pharma R&D head bolts post after 6 months—Chutes & Ladders
Dec 4, 2020 9:30am
Merck taps 4D pharma for bacterial vaccine R&D project
Oct 8, 2019 9:08am
4D Pharma acquires Spanish CRO Instituto Biomar
Apr 12, 2016 3:34am
